Locations:
Search IconSearch

Research

bloodtest_650x450
April 10, 2018/Cancer/Research

STRIVE Study Supports Development of a Blood Test for Early Breast Cancer Detection

Investigating cell-free nucleic acids for cancer detection

glioblastoma_650x450

Vasorin: The Achilles’ Heel of Glioma Stem Cells

Hypoxic induction of vasorin regulates Notch1 turnover

Myelofibrosis cells
April 5, 2018/Cancer/Research

How a Myelofibrosis Drug PERSISTed Through an FDA Hold

Final results of PERSIST-2 confirm benefit; PAC203 enrolling

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

renal-cell-cance_650x450
March 21, 2018/Cancer/Research

Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer

Positive results point to a better prognosis for intractable disease

Breast cancer cell

How Cancer Stem Cells Drive Triple-Negative Breast Cancer

Discovery of mechanistic links may lead to new therapies

statins_650x450
January 4, 2018/Cancer/Research

Statins Inhibit In Vitro Growth and Increase Radiation Sensitivity of Colorectal Cancer Cells

Cardiovascular drug affects cancer cell protein pathways

Lab_650x450
January 3, 2018/Cancer/Research

Next-Generation Sequencing of Tumor Tissue Versus Blood in Patients with Advanced Urothelial Cancer

Study examines concordance between commercially available genomic tests

maciejewski_650x450
December 11, 2017/Cancer/Research

Exploiting Vulnerability of Impaired DNA Repair Creates New Therapeutic Strategy in Acute Myeloid Leukemia

Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib

BackPage 22 of 26Next

Advertisement

Ad